. 2020 Jun 17;9(4):406–412. doi: 10.1093/toxres/tfaa040

Table 3.

Protective effect of AgNPs on activities of SOD and CAT and ATPase in kidney homogenate

Treatments	SOD (U/mg protein)	CAT (U/mg protein)	ATPase (mg Pi/100 g/min)
Control	69.0 ± 3.81	83.0 ± 4.58	1829 ± 101
AgNPs per se	71.0 ± 3.92	82.0 ± 4.53	1830 ± 101
APAP per se	36.0 ± 1.99^b	39.0 ± 2.15^b	1021 ± 56.4^b
APAP + AgNPs 50 μg/kg % protection	55.0 ± 3.04^* (57%)	60.0 ± 3.31^* (48%)	1230 ± 68.0^* (26%)
APAP + AgNPs 100 μg/kg % protection	60.5 ± 3.34^* (74%)	71.5 ± 3.95^* (74%)	1550 ± 85.6^* (65%)
APAP + AgNPs 150 μg/kg % protection	61.6 ± 3.40^* (77%)	71.8 ± 3.96^* (74%)	1560 ± 86.2^* (67%)
APAP + S 50 mg/kg % protection	66.0 ± 3.64^* (91%)	79.6 ± 4.40^* (92%)	1640 ± 90.6^* (77%)
ANOVA	14.868^a	19.061^a	14.776^a

Data are mean ± SEM; N = 6.

^aSignificant at 5% for ANOVA.

^bAPAP vs control.

^*APAP + therapy vs APAP at P ≤ 0.05.